Rock Springs Capital Management LP Fulcrum Therapeutics, Inc. Transaction History

Rock Springs Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$2.83 - $13.99 $970,924 - $4.8 Million	343,083 Added 89.21%	727,673 $2.07 Million
Q2 2022 Aug 15, 2022	SELL	$4.2 - $24.0 $210,000 - $1.2 Million	-50,000 Reduced 11.51%	384,590 $1.88 Million
Q1 2022 May 16, 2022	SELL	$9.96 - $23.65 $223,104 - $529,760	-22,400 Reduced 4.9%	434,590 $10.3 Million
Q4 2021 Feb 14, 2022	BUY	$14.0 - $28.44 $23,800 - $48,348	1,700 Added 0.37%	456,990 $8.08 Million
Q3 2021 Nov 15, 2021	BUY	$7.28 - $30.97 $3.31 Million - $14.1 Million	455,290 New	455,290 $12.8 Million

150

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $237M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.